Details for New Drug Application (NDA): 020010
✉ Email this page to a colleague
NDA 020010 describes LOTRISONE, which is a drug marketed by Organon and Merck Sharp Dohme and is included in two NDAs. Additional details are available on the LOTRISONE profile page.
The generic ingredient in LOTRISONE is betamethasone dipropionate; clotrimazole. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; clotrimazole profile page.
The generic ingredient in LOTRISONE is betamethasone dipropionate; clotrimazole. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; clotrimazole profile page.
Summary for 020010
| Tradename: | LOTRISONE |
| Applicant: | Merck Sharp Dohme |
| Ingredient: | betamethasone dipropionate; clotrimazole |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | LOTION;TOPICAL | Strength | EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 8, 2000 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
